The advantages of UK Biobank's open access strategy for health research

Megan Conroy, Jonathan Sellors, Mark Effingham, Thomas J Littlejohns, Chris Boultwood, Lorraine Gillions, Catherine Sudlow, Rory Collins, Naomi E Allen

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Ready access to health research studies is becoming more important as researchers, and their funders, seek to maximise the opportunities for scientific innovation and health improvements. Large-scale population-based prospective studies are particularly useful for multidisciplinary research into the causes, treatment and prevention of many different diseases. UK Biobank has been established as an open-access resource for public health research, with the intention of making the data as widely available as possible in an equitable and transparent manner. Access to UK Biobank's unique breadth of phenotypic and genetic data has attracted researchers worldwide from across academia and industry. As a consequence, it has enabled scientists to perform world-leading collaborative research. Moreover, open access to an already deeply characterized cohort has encouraged both public and private sector investment in further enhancements to make UK Biobank an unparalleled resource for public health research and an exemplar for the development of open access approaches for other studies.

Original languageEnglish
JournalJournal of Internal Medicine
Early online date8 Jul 2019
Publication statusE-pub ahead of print - 8 Jul 2019


Dive into the research topics of 'The advantages of UK Biobank's open access strategy for health research'. Together they form a unique fingerprint.

Cite this